- Press Release Distribution

Shape-shifting immune cells offer new insights into cancer immunotherapy

Research sheds light on long-standing question

Shape-shifting immune cells offer new insights into cancer immunotherapy
( Macrophages, a type of white blood cell that can destroy invading pathogens, have an innate ability to infiltrate tumor cells, making them a potentially important tool in treatments that use transplanted cells to fight disease, known as cell therapy.  In the lab, macrophages show a lot of promise in treating cancer but so far, clinical trials have been a disappointment and biologists are trying to figure out why.

But what if it’s not a biological problem?

In a recent paper, researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) approached the failure of macrophages in clinical trials from an engineering perspective. 

The research team, led by Samir Mitragotri, the Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at SEAS, looked at the physical barriers that might be preventing macrophages from reaching their target in the first place. 

By combining microscopy with machine learning, the team found that a specific phenotype of macrophage was better at traveling to the tumor than others — and it’s not the one that researchers commonly use in the clinic for cancer therapies. 

The research was published Applied Physics Reviews.

“Our engineering approach led us to question whether the poor therapeutic outcome of macrophages in cell therapies can in part originate from their inability to get into the tumor in the first place,” said Mitragotri. “And indeed, our results show that different phenotypes exhibit different penetration into the tumor. This provides an interesting physics-based hypothesis for the poor clinical outcome of previously reported macrophage therapies and provides a counter- and complimentary hypothesis to the classical biology-based paradigm.”

There are multiple types of macrophages, simplified as M0, M1, and M2. Of the three, M1 macrophages have the best tumor-fighting capacities and therefore have been used the most for cell therapies. But they have yielded disappointing results in clinical trials.  

Mitragotri and his team looked at how each of the three different phenotypes could move through a complex hydrogel and into a tumor in a petri dish. 

“We basically wanted to measure how well the transport mechanics and GPS of these different macrophages worked in a complex environment,” said Kolade Adebowale, a postdoctoral fellow at SEAS and first author of the paper. “We found that the M1 phenotype, anti-tumor microphage, seem to have trouble finding their targets, almost like their GPS wasn’t working. But the M0 phenotype seemed to have a really good map.”

The big question is why. 

It’s well known that macrophages exist in various shapes and some phenotypes are really good at changing their shape. Adebowale and the team found a correlation between shape-shifting abilities and transport efficiency — meaning the better the macrophage was at shape shifting, the better able they were to get to the tumor. 

And, as it turned out, M1 macrophages are the worst of the three when it comes to shapeshifting. 

“Our study demonstrates that the reduced transport of M1 macrophages compared to M0 macrophages is correlated with their reduced ability to undergo shape transformations,” said Adebowale. “We hope that these findings shed new light on the biophysics of macrophage migration and delivery of macrophage cell therapies.”

“There is tremendous potential in utilizing macrophages to mediate anti-tumor immune responses in human tumors and clinical trials are ongoing to treat patients with macrophages,” said Jennifer Guerriero, Assistant Professor at Harvard Medical School, lead investigator of Brigham and Women’s Hospital Breast Oncology Program and co-author of the study. “We learned in this study that, surprisingly, macrophages that resemble an M0 phenotype were most efficient at getting to their target. These data will have an immediate impact on clinical trials are likely to transform the next generation of macrophage-mediated therapies.” 

The research was supported by the National Science Foundation under Award No. 2138064.


[Attachments] See images for this press release:
Shape-shifting immune cells offer new insights into cancer immunotherapy


All aquatic species in river mouths are contaminated by microplastics

All aquatic species in river mouths are contaminated by microplastics
All aquatic species in the river mouths flowing into the Mediterranean Sea and Atlantic Ocean are contaminated with microplastics, with molluscs being the most affected due to their ability to filter water. Rivers are one of the main sources of pollution by microplastics (5 to 0.0001 mm in size) and nanoplastics (smaller than 0.0001mm) in the oceans. Estuaries, as transition zones between rivers and the sea, are major hotspots for the accumulation of these particles, which are retained in sediments. They pose a threat to aquatic ecosystems given their ability to capture harmful chemicals from the surrounding environment, ...

Smaller hippocampus linked to cognitive decline

MINNEAPOLIS – With the rise of new drugs that can target the amyloid-beta plaques in the brain that are an early sign of Alzheimer’s disease, new ways are needed to determine whether memory loss and thinking problems are due to Alzheimer’s disease or another neurodegenerative disorder. A new study published in the November 15, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology, shows that shrinkage in the hippocampus area of the brain is associated with cognitive decline, even in people who don’t have amyloid plaques in the brain. The hippocampus plays a role in memory. “These results suggest ...

ECOG-ACRIN and PrECOG announce multiple presentations at the American Society of Hematology (ASH) 2023 annual meeting

Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and PrECOG, LLC, will present six oral and three poster presentations at the 65th American Society of Hematology (ASH) Meeting & Exposition, occurring in San Diego, California and virtually December 9-12, 2023. The presentations focus on treatments for acute leukemias and lymphomas.   Among the data are the promising results of the phase 2 PrE0405 trial, which evaluated bendamustine, rituximab, and venetoclax for the initial treatment of mantle cell lymphoma in older patients. Other ...

Use it or lose it: New robotic system assesses mobility after stroke

Use it or lose it: New robotic system assesses mobility after stroke
Embargoed: Not for Release Until 2:00 pm U.S. Eastern Time Wednesday, 15 November 2023 Stroke is a leading cause of long-term disability worldwide. Each year more than 15 million people worldwide have strokes, and three-quarters of stroke survivors will experience impairment, weakness and paralysis in their arms and hands. Many stroke survivors rely on their stronger arm to complete daily tasks, from carrying groceries to combing their hair, even when the weaker arm has the potential to improve. Breaking this habit, known as “arm nonuse” or “learned nonuse,” can improve strength and prevent injury. But, determining how much ...

Birds set foot near South Pole in Early Cretaceous, Australian tracks show

Birds set foot near South Pole in Early Cretaceous, Australian tracks show
The discovery of 27 avian footprints on the southern Australia coast — dating back to the Early Cretaceous when Australia was still connected to Antarctica — opens another window onto early avian evolution and possible migratory behavior. PLOS ONE published the discovery of some of the oldest, positively identified bird tracks in the Southern Hemisphere, dated to between 120 million and 128 million years ago. “Most of the bird tracks and body fossils dating as far back as the Early Cretaceous are from the Northern Hemisphere, particularly from Asia,” says Anthony Martin, first ...

University of Kentucky bioengineer designs tools to improve treatment for head and neck cancer

University of Kentucky bioengineer designs tools to improve treatment for head and neck cancer
LEXINGTON, Ky. (Nov. 15, 2023) — One University of Kentucky researcher is working to develop new techniques for radiation treatment to improve survival rates of patients with a specific type of cancer. Caigang Zhu, Ph.D., is an assistant professor in the Department of Biomedical Engineering in the UK Stanley and Karen Pigman College of Engineering. He is also a member of the Molecular and Cellular Oncology Research Program at the UK Markey Cancer Center. The National Institute of Dental and Craniofacial Research of ...

New plant hardiness map, used by gardeners nationwide and based on OSU climate data, unveiled

CORVALLIS, Ore. – The U.S. Department of Agriculture today released its new Plant Hardiness Zone Map, the national standard by which gardeners can determine which plants are most likely to survive the coldest winter temperatures at a certain location. The USDA describes the latest map, jointly developed by Oregon State University’s PRISM Climate Group and the USDA’s Agricultural Research Service, as the most accurate and detailed it has ever released. PRISM, part of the OSU College of Engineering, stands for Parameter-elevation Regressions on Independent Slopes Model. The previous version of the plant hardiness map, also based ...

An engineered protein enhances memory

Neuroscientists at the Faculty of Medicine and Surgery of the Catholic University, Rome, and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS have genetically modified a molecule, the protein LIMK1, which is normally active in the brain, with a key role in memory. They added a "molecular switch" that is activated by administering a drug, rapamycin, known for its several anti-aging effects on the brain. This is the result of a study published in the journal Science Advances, which involves the Catholic ...

New near-complete skeleton of a bird-like dinosaur is found in a position which suggests it slept like modern birds

New near-complete skeleton of a bird-like dinosaur is found in a position which suggests it slept like modern birds
New near-complete skeleton of a bird-like dinosaur is found in a position which suggests it slept like modern birds ### Article URL: Article Title: A new alvarezsaurid dinosaur (Theropoda, Alvarezsauria) from the Upper Cretaceous Baruungoyot Formation of Mongolia provides insights for bird-like sleeping behavior in non-avian dinosaurs Author Countries: Japan, Mongolia Funding: Funding for this project was granted by Research Fellowships from the Japan Society for the Promotion of Science (JSPS 21J12938) (to KK) and Ami Koshimizu (Endless Glory Office Restart Co., Ltd.) (to KK). The funders had ...

Radiocarbon dating meets Egyptology and Biblical accounts in the city of Gezer

Radiocarbon dating meets Egyptology and Biblical accounts in the city of Gezer
New dates provide detailed insights into the timing of events in the ancient city of Gezer, according to a study published November 15, 2023 in the open-access journal PLOS ONE by Lyndelle Webster of the Austrian Academy of Sciences and colleagues. Gezer is an ancient southern Levantine city, well known from Egyptian, Assyrian, and Biblical texts and associated with stories of power struggles and significant historical figures. It is also a rich archaeological site with abundant Bronze Age and Iron Age remains and with great potential for research into the daily lives of its denizens. Recent excavations at the site have uncovered a continuous stratigraphic ...


UK/Portuguese study strongly suggests antibiotic-resistant “superbugs” are being passed from cats and dogs to their owners

Researchers study effects of solvation and ion valency on metallopolymers

Physicists solve puzzle about ancient galaxy found by Webb telescope

Clear guidelines needed for synthetic data to ensure transparency, accountability and fairness study says

Report finds significant gender and racial inequities in the educational measurement profession

University of Houston and Scotland’s Heriot-Watt University forge strategic energy alliance

Rice team demonstrates miniature brain stimulator in humans

Jennifer Stinson receives prestigious Barer-Flood Prize in health services research

First insights into the genetic bottleneck characterizing early sheep husbandry in the Neolithic period

Theories that explain the crisis in democracy are inadequate for Latin America, experts say

Starving cells hijack protein transport stations

Where have all the right whales gone?

Researchers find no link between COVID-19 virus and development of asthma in children

Cell’s ‘garbage disposal’ may have another role: helping neurons near skin sense the environment

Study reveals potential to reverse lung fibrosis using the body’s own healing technique

International team co-led by a BSC researcher discovers more than 50 new deep-sea species in one of the most unexplored areas of the planet

Cleveland Innovation District partners exceeding many targets set by state and JobsOhio

A third of women experience migraines associated with menstruation, most commonly when premenopausal

MD Anderson Research Highlights for April 12, 2024

Soft Robotics appoints new Deputy Editor-in-Chief, Barbara Mazzolai, PhD

Wiley releases Mass Spectra of Designer Drugs 2024 to accelerate forensics analysis of fentanyls, cannabinoids, and more

Freestanding emergency departments are popular, but do they function as intended?

University of Cincinnati experts present at national neurology conference

Bonobos are more aggressive than previously thought

How seaweed became multicellular

Melanomas resist drugs by ‘breaking’ genes

Africa’s iconic flamingos threatened by rising lake levels, study shows

Vaccination timeliness among US children ages 0-19 months

Changes in permanent contraception procedures among young adults following the Dobbs decision

Semaglutide vs endoscopic sleeve gastroplasty for weight loss

[] Shape-shifting immune cells offer new insights into cancer immunotherapy
Research sheds light on long-standing question